The causative agent of CoV disease 2019 is a new coronavirus CoV type 2, affecting the
respiratory tract with severe manifestations (SARS-CoV-2). Covid-19 is mainly symptomless …

Drug repurposing is of interest for therapeutics innovation in many human diseases
including coronavirus disease 2019 (COVID-19). Methodological innovations in drug …

Severe acute respiratory syndrome (SARS) is a highly contagious viral respiratory illness.
This illness is spurred on by a coronavirus known as SARS-associated coronavirus (SARS …

Chemometrics and machine learning are artificial intelligence-based methods stirring a
transformative change in chemistry. Organic synthesis, drug discovery and analytical …

Because translating the growing body of knowledge about human disease into treatments
has been slower than expected, the application of machine learning techniques to drug …

Respiratory viral diseases are among the most important causes of disability, morbidity, and
death worldwide. Due to the limited efficacy or side effects of many current therapies and the …

A viral infection involves entry and replication of viral nucleic acid in a host organism,
subsequently leading to biochemical and structural alterations in the host cell. In the case of …

Identification of disease‐drug associations is an effective strategy for drug repurposing,
especially in searching old drugs for newly emerged diseases like COVID‐19. In this study …

Abstract Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous, chronic
inflammatory process of the lungs and, like other complex diseases, is caused by both …

Ongoing mutations in the coronavirus family, especially beta-coronaviruses, raise new
concerns about the possibility of new unexpected outbreaks. Therefore, it is crucial to …